Добірка наукової літератури з теми "Atrial fibrillation; myocardial infarction"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Atrial fibrillation; myocardial infarction".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Atrial fibrillation; myocardial infarction"
Vermond, Rob A., Isabelle C. Van Gelder, Harry J. Crijns, and Michiel Rienstra. "Does Myocardial Infarction Beget Atrial Fibrillation and Atrial Fibrillation Beget Myocardial Infarction?" Circulation 131, no. 21 (May 26, 2015): 1824–26. http://dx.doi.org/10.1161/circulationaha.115.016595.
Повний текст джерелаBhattarai, Radha, and Sergey Anatolevich Sayganov. "Atrial Fibrillation in Acute Myocardial Infarction." Nepalese Heart Journal 12, no. 1 (March 24, 2015): 15–20. http://dx.doi.org/10.3126/njh.v12i1.12327.
Повний текст джерелаNambiar, Dr Supriya D. "Cardiac and Extra Cardiac Predictors and Complications of Acute Atrial Fibrillation Complicating ST Elevation Myocardial Infarction (STEMI) ST Elevation myocardial infarction Acute Atrial Fibrillation (STAAF) Study." Journal of Medical Science And clinical Research 05, no. 05 (May 23, 2017): 22124–34. http://dx.doi.org/10.18535/jmscr/v5i5.139.
Повний текст джерелаJortveit, Jarle, Are H. Pripp, Jørund Langørgen, and Sigrun Halvorsen. "Poor adherence to guideline recommendations among patients with atrial fibrillation and acute myocardial infarction." European Journal of Preventive Cardiology 26, no. 13 (April 9, 2019): 1373–82. http://dx.doi.org/10.1177/2047487319841940.
Повний текст джерелаAlasady, Muayad, Nicholas J. Shipp, Anthony G. Brooks, Han S. Lim, Dennis H. Lau, David Barlow, Pawel Kuklik, et al. "Myocardial Infarction and Atrial Fibrillation." Circulation: Arrhythmia and Electrophysiology 6, no. 4 (August 2013): 738–45. http://dx.doi.org/10.1161/circep.113.000163.
Повний текст джерелаDukes, Jonathan W., and Gregory M. Marcus. "Atrial Fibrillation Begets Myocardial Infarction." JAMA Internal Medicine 174, no. 1 (January 1, 2014): 5. http://dx.doi.org/10.1001/jamainternmed.2013.11392.
Повний текст джерелаNeobutov, Nikolai, and Sergey Kolbasnikov. "The state of the myocardium, the vascular wall and the severity of anxiety-depressive disorders in patients with myocardial infarction and atrial fibrillation." Archiv Euromedica 9, no. 1 (April 30, 2019): 109–12. http://dx.doi.org/10.35630/2199-885x/2019/9/1/109.
Повний текст джерелаTomcsányi, János, Katalin Takó, and Balázs Sármán. "Recidív akut myocardialis infarctus pitvarfibrilláció miatt." Orvosi Hetilap 157, no. 5 (January 2016): 191–93. http://dx.doi.org/10.1556/650.2016.30349.
Повний текст джерелаCheng, Liting, and Yongquan Wu. "Mesenteric Ischemia and Myocardial Infarction Associated with Atrial Fibrillation." Case Reports in Cardiology 2018 (2018): 1–3. http://dx.doi.org/10.1155/2018/7860397.
Повний текст джерелаRadha, B., S. A. Sayganov, and T. Y. Gromiko. "ATRIAL FIBRILLATION IN PATIENTS WITH INFERIOR MYOCARDIAL INFARCTION." HERALD of North-Western State Medical University named after I.I. Mechnikov 7, no. 1 (March 15, 2015): 46–52. http://dx.doi.org/10.17816/mechnikov20157146-52.
Повний текст джерелаДисертації з теми "Atrial fibrillation; myocardial infarction"
Hedberg, P. (Pirjo). "Advances in routine measurement of cardiac damage and cardiovascular risk markers." Doctoral thesis, University of Oulu, 2005. http://urn.fi/urn:isbn:9514276388.
Повний текст джерелаBatra, Gorav. "Atrial Fibrillation in the setting of Coronary Artery Disease : Risks and outcomes with different treatment options." Doctoral thesis, Uppsala universitet, Kardiologi, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-320541.
Повний текст джерелаGibbons, David D. "Stabilization of the Cardiac Nervous System During Cardiac Stress Induces Cardioprotection." Digital Commons @ East Tennessee State University, 2012. https://dc.etsu.edu/etd/1219.
Повний текст джерелаLeal, João Carlos Ferreira. "Troponina I cardiaca como marcador de risco para fibrilação atrial no pos-operatorio imediato de pacientes submetidos a revascularização miocardica." [s.n.], 2008. http://repositorio.unicamp.br/jspui/handle/REPOSIP/308835.
Повний текст джерелаTese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciencias Medicas
Made available in DSpace on 2018-08-11T14:35:59Z (GMT). No. of bitstreams: 1 Leal_JoaoCarlosFerreira_D.pdf: 5038174 bytes, checksum: ad94b28be3168b7ddcb5c89801eef75f (MD5) Previous issue date: 2008
Resumo: Objetivo: avaliar se há ou não associação na ocorrência de fibrilação atrial (FA) e os níveis séricos de troponina I cardíaca no pós-operatório imediato da revascularização do miocárdio (RM). Casuística e Método: estudo retrospectivo incluindo 95 pacientes submetidos à revascularização cirúrgica do miocárdio, entre dezembro de 1996 a março de 1998. Os pacientes foram divididos em 2 grupos: Grupo I constituído de 25 pacientes (26,31%) com fibrilação atrial (FA); Grupo II constituído de 70 pacientes (73,69%) sem FA. As variáveis avaliadas foram: tempos de circulação extracorpórea (CEC), pinçamento aórtico e isquemia, fração de ejeção e o diâmetro do átrio esquerdo. O ritmo cardíaco foi avaliado por monitorização contínua por exames eletrocardiográficos durante o período de internação. Todos os pacientes foram submetidos à dosagens dos níveis séricos de troponina-I cardíaca no pré e pós-operatório imediato da RM pelo método de quimioluminiscência, admitindo-se como normais valores abaixo de 0,1 ng/ml. Resultados: Os grupos I e II não apresentaram diferenças significantes quanto à fração de ejeção, diâmetro do átrio esquerdo, tempos de pinçamento da aorta e de isquemia. O tempo de CEC mostrou diferença significante entre os grupos. A análise pareada dos valores séricos da troponina I cardíaca dos pacientes dos grupos I e II no pré-operatório não mostrou diferença significante, com valor de P=0,9689. No pós-operatório, houve diferença significante entre os grupos, sendo que o grupo I mostrou maior aumento em relação ao II com P=0,0018. O valor de corte de troponina I cardíaca que melhor se associou com ocorrência de FA foi = 0,936 µg/ L. Conclusão: A ocorrência da FA está associada com os níveis séricos de troponina I cardíaca no pós-operatório imediato da RM quando considerado o valor de corte = 0,936 µg/L, sugerindo que a troponina I cardíaca é um marcador para FA e alertando para a necessidade de medidas diagnósticas ou terapêuticas preventivas
Abstract: Objective: To evaluate if there is any association among atrial fibrillation (AF) events and serum cardiac Troponin I levels in the immediate postoperative period of myocardium revascularization (MR). Patients and method: A retrospective study was made of 95 patients who underwent myocardial revascularization surgery between December 1996 and March 1998. The patients were divided into 2 groups: Group I comprised 25 patients (26.31%) who presented with atrial fibrillation (AF) and Group II 70 patients (73.69%) without AF. The variables evaluated were: time of extracorporeal circulation (ECC), aortic clamping and ischemia, ejection fraction and the diameter of the left atrium. The heart rhythm was evaluated by continuous monitoring by electrocardiography during hospitalization. The serum cardiac Troponin I levels were measured for all patients in the pre- and immediate postoperative periods of MR by chemoluminescence; normal values were consider to be below 0.1 ng/mL. Results: There were no significant differences between groups in respect to the ejection fraction, diameter of the left atrium and duration of aortic clamping and ischemia. The ECC time gave a significant difference between the groups. A comparison of the serum cardiac Troponin I levels of the patients in both groups in the preoperative period did not prove to be statistically significant (P-value = 0.9689). In the postoperative period however, there was a significant difference; Group I presented with a greater increase when compared to Group II (P-value = 0.0018). Levels of cardiac Troponin I =0.936 µg/L were associated with a risk of AF. Conclusion: AF events are associated with serum cardiac Troponin I levels =0.936 µg/L in the immediate postoperative period of MR. This suggests that cardiac Troponin I is a marker for AF, highlighting the necessity of diagnostic investigations and preventive therapeutic procedures
Doutorado
Cirurgia
Doutor em Cirurgia
Stamboul, Karim. "La fibrillation atriale, silencieuse ou symptomatique, compliquant un infarctus du myocarde : déterminants, impact pronostique et rôle des dérivés méthylés de la L-arginine et du stress oxydatif." Thesis, Dijon, 2015. http://www.theses.fr/2015DIJOMU01/document.
Повний текст джерелаAtrial fibrillation (AF) is a frequent complication of acute myocardial infarction (AMI) with a poorer prognosis. Silent atrial fibrillation has been suggested to be frequent after AMI. However, most part of the studies has targeted only paroxysmal or persistent AF. Thus, Reduced Nitric Oxide availability and endothelial dysfunction has been recently recognized as a possible contributor to altered prognosis in AF. Asymmetric dimethylarginine (ADMA) can inhibit nitric oxide synthase and leads to endothelial dysfunction, inflammation and oxidative stress in multiple cardiovascular diseases. However, any study has addressed the relationship between ADMA levels and the occurrence of AF in AMI.We aimed to assess in-hospital and 1-year prognosis in patients experiencing silent AF in AMI and evaluate the potential relationship between dimethylarginines plasma levels and the occurrence AF after acute myocardial infarction.Our first prospective study shows for the first time that silent AF is more frequent than symptomatic AF after AMI and is associated with a worse prognosis.Our second work confirms the impact of silent AF on prognosis, with a prognosis that remains worse one year after the acute phase of MI. Our third work proved that ADMA is independently associated with symptomatic AF after AMI and strengthen the capacity to estimate symptomatic AF occurrence. In conclusion our studies highlight that AF is not a negligible event after AMI, in particular silent AF. That suggests that systematic screening and specific management should be investigated in order to improve outcomes of patients. ADMA appears to be a potential predictor of AF after AMI, because of its significant association
Hållmarker, Ulf. "Epidemiological Studies on Long Distance Cross-Country Skiers : Participants in the Vasaloppet 1955-2010." Doctoral thesis, Uppsala universitet, Uppsala kliniska forskningscentrum (UCR), 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-260994.
Повний текст джерелаConic, Rosalynn Ruzica Zoran. "USING PSORIASIS AS A MODEL TO IDENTIFY UNIQUE BIOMARKERS." Case Western Reserve University School of Graduate Studies / OhioLINK, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=case1554485554569272.
Повний текст джерелаLe, Quang Khai. "Troubles du rythme cardiaque dans les modèles murins transgéniques." Thèse, Nantes, 2010. http://hdl.handle.net/1866/4903.
Повний текст джерелаCardiovascular disease is the leading cause of death in the world each year. If no action is taken to improve cardiovascular health and current trends continue, WHO estimates that 25% more healthy life years will be lost to cardiovascular disease globally by 2020. Cardiac hypertrophy is the consequence of an excessive workload of the heart muscle leading to cardiac remodeling process. As the workload increases, the ventricular walls grow thicker, lose elasticity and eventually may fail to pump with as much force as a healthy heart. Furthermore, hypertrophied myocardium is not physiologically normal and may confer a predisposition to potentially fatal arrhythmias. Generally, the causal mechanism is ventricular fibrillation, a cardiac rhythm disorder which is irreversible but the pathophysiological mechanisms are complex and poorly understood. The functional consequences of mutations or ionic remodeling are relatively simple to study in vitro, but their role in the pathophysiology of arrhythmias in vivo is more difficult to grasp. Among the different animal models developed in cardiac arrhythmias research, the mouse is increasingly used because of our ability to mutate, knock-out or over-express genes of interest. The objective of my thesis was to study the role of ion channels in physiology as well as cardiac pathophysiology, particularly in the involvement of the occurrence of cardiac arrhythmias in vivo. This thesis will improve our understanding of the role of genetic abnormalities involving ionic remodeling in the pathogenesis of the heart and may also open new therapeutic perspectives in the treatment of cardiac remodeling as well as sudden cardiac death.
Thèse en cotutelle avec Université de Nantes - Pays de La Loire - France (2005-2010)
Legallois, Damien. "Paramètres biologiques et échocardiographiques et remodelage ventriculaire gauche après syndrome coronarien aigu avec sus-décalage du segment ST Definition of left ventricular remodelling following ST-elevation myocardial infarction: a systematic review of cardiac magnetic resonance studies in the past decade Left atrial strain quantified after myocardial infarction is associated with ventricular remodeling The relationship between circulating biomarkers and left ventricular remodeling after myocardial infarction: an updated review Serum neprilysin levels are associated with myocardial stunning after ST-elevation myocardial infarction Is plasma level of Coenzyme Q10 a predictive marker for left ventricular remodeling after revascularization for ST-segment elevation myocardial infarction ?" Thesis, Normandie, 2020. http://www.theses.fr/2020NORMC429.
Повний текст джерелаLeft ventricular remodeling is a common complication in patients following acutemyocardial infarction and may lead to heart failure. Some baseline parameters are associated withremodeling at follow-up, allowing to better discriminate patients with an increased risk of heart failureto optimize therapeutics. This work has two axes, focused on imaging and biological parametersassociated with left ventricular remodeling, respectively. First, we reviewed past studies that definedremodeling using cardiac magnetic resonance imaging. Then, we studied the association betweensome echocardiographic parameters (left atrial strain and diastolic intraventricular pressure gradient)and left ventricular remodeling after ST-elevation myocardial infarction. In the other axis, wereviewed biomarkers that have been associated with left ventricular remodeling in prior studies. Then,we investigated the association between neprilysin and coenzyme Q10 levels and left ventricularremodeling in STEMI patients
Sambola, Antonia, Pau Rello, Toni Soriano, Deepak L. Bhatt, Vinay Pasupuleti, Christopher P. Cannon, C. Michael Gibson, et al. "Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis." Elsevier Ltd, 2020. http://hdl.handle.net/10757/655507.
Повний текст джерелаJanssen Pharmaceuticals
Revisión por pares
Книги з теми "Atrial fibrillation; myocardial infarction"
Meyer, Mark Louis. Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. [New Haven, Conn: s.n.], 1994.
Знайти повний текст джерелаJohannes, Janse Michiel, ed. The ventricular arrhythmias of ischemia and infarction: Electrophysiological mechanisms. Mount Kisco, NY: Futura Pub. Co., 1993.
Знайти повний текст джерелаBraidwood Commission on Conducted Energy Weapon Use (B.C.). Restoring public confidence: Restricting the use of conducted energy weapons. Victoria, B.C: Braidwood Commission on Conducted Energy Weapon Use, 2009.
Знайти повний текст джерелаBowker, Lesley K., James D. Price, Ku Shah, and Sarah C. Smith. Cardiovascular. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198738381.003.0010.
Повний текст джерелаBrady, Peter A. Specific Arrhythmias and Syncope. Oxford University Press, 2012. http://dx.doi.org/10.1093/med/9780199755691.003.0044.
Повний текст джерелаTurc, Guillaume, David Calvet, and Jean-Louis Mas. Cardiac aetiology. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198722366.003.0005.
Повний текст джерелаBanerjee, Ashis, and Clara Oliver. Cardiac emergencies. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198786870.003.0009.
Повний текст джерелаKelley, Roger E. Cardiac Disease. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199937837.003.0188.
Повний текст джерелаSinnaeve, Peter, and Frans Van de Werf. Fibrinolytic, antithrombotic, and antiplatelet drugs in acute coronary syndromes. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199687039.003.0044.
Повний текст джерелаSinnaeve, Peter, and Frans Van de Werf. Fibrinolytic, antithrombotic, and antiplatelet drugs in acute coronary syndromes. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199687039.003.0044_update_001.
Повний текст джерелаЧастини книг з теми "Atrial fibrillation; myocardial infarction"
Musat, Dan L., Jonathan S. Steinberg, Delia Cotiga, and Eyal Herzog. "Arrhythmias Complicating Acute Myocardial Infarction: Atrial Tachyarrhythmias Including Atrial Fibrillation and Atrial Flutter." In Acute Coronary Syndrome, 175–89. London: Springer London, 2008. http://dx.doi.org/10.1007/978-1-84628-869-2_17.
Повний текст джерелаGargiulo, Giuseppe, and Davide Capodanno. "Atrial Fibrillation on Vitamin K Antagonist Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction." In Atrial Fibrillation and Percutaneous Coronary Intervention, 79–94. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-42400-2_5.
Повний текст джерелаKiviniemi, Tuomas O., and K. E. Juhani Airaksinen. "Atrial Fibrillation on Vitamin K Antagonist Oral Anticoagulant Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Acute Myocardial Infarction." In Atrial Fibrillation and Percutaneous Coronary Intervention, 95–120. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-42400-2_6.
Повний текст джерелаZuin, G., M. Celestre, and F. Di Pede. "Prognosis and Management of Atrial Fibrillation in Different Clinical Settings: Acute Myocardial Infarction." In Cardiac Arrhythmias 2005, 127–30. Milano: Springer Milan, 2006. http://dx.doi.org/10.1007/88-470-0371-7_17.
Повний текст джерелаDe Ferrari, Gaetano M., Valentina De Regibus, Vincenzo Gionti, Daniela Civardi, Roberto Insolia, Matteo Pedrazzini, Davide Gentilini, Annamaria Di Blasio, Lia Crotti, and Peter J. Schwartz. "PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic Basis." In Contributions to Statistics, 85–96. Milano: Springer Milan, 2013. http://dx.doi.org/10.1007/978-88-470-5379-3_6.
Повний текст джерелаMarciniak, Maciej, Hermenegild Arevalo, Jacob Tfelt-Hansen, Kiril A. Ahtarovski, Thomas Jespersen, Reza Jabbari, Charlotte Glinge, et al. "A Multiple Kernel Learning Framework to Investigate the Relationship Between Ventricular Fibrillation and First Myocardial Infarction." In Functional Imaging and Modelling of the Heart, 161–71. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-59448-4_16.
Повний текст джерелаMacMahon, Stephen, and Salim Yusuf. "Effects of Lidocaine on Ventricular Fibrillation, Asystole, and Early Death in Patients with Suspected Acute Myocardial Infarction." In Acute Coronary Care 1987, 51–60. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-2337-2_4.
Повний текст джерелаHiremath, Jagdish, and Kaushik Sheth. "Atrial Fibrillation Complicating Acute Myocardial Infarction." In Atrial Fibrillation Update: A Textbook of Cardiology, 407. Jaypee Brothers Medical Publishers (P) Ltd., 2017. http://dx.doi.org/10.5005/jp/books/13034_66.
Повний текст джерелаKumar, Sunil, and Manish Ruhela. "Takotsubo Mimicking Acute Myocardial Infarction and Atrial Fibrillation." In Atrial Fibrillation Update: A Textbook of Cardiology, 219. Jaypee Brothers Medical Publishers (P) Ltd., 2017. http://dx.doi.org/10.5005/jp/books/13034_41.
Повний текст джерелаPrescott, Eva. "Sex and gender differences overview." In ESC CardioMed, edited by Noel Bairey Merz, 2827–30. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198784906.003.0675.
Повний текст джерелаТези доповідей конференцій з теми "Atrial fibrillation; myocardial infarction"
Ali, M., A. Ibrahim, P. Kyaw, A. Kulkarni, and M. Siddique. "Right Atrial Thrombus Associated with Concurrent Myocardial Infarction and Pulmonary Embolism." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3467.
Повний текст джерелаFunamoto, Kenichi, Ryo Koizumi, Toshiyuki Hayase, Muneichi Shibata, and Tomoyuki Yambe. "Hemodynamic Changes in the Left Atrium due to Atrial Fibrillation." In ASME 2011 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2011. http://dx.doi.org/10.1115/sbc2011-53817.
Повний текст джерелаHONJO, HARUO. "ELECTROPHYSIOLOGY OF PULMONARY VEIN MYOCARDIAL SLEEVES AND THEIR ROLE IN ATRIAL FIBRILLATION." In Proceedings of the 31st International Congress on Electrocardiology. WORLD SCIENTIFIC, 2005. http://dx.doi.org/10.1142/9789812702234_0004.
Повний текст джерелаOgawa, Emiyu, Arisa Ito, and Tsunenori Arai. "Fundamental study on photodynamic therapy for atrial fibrillation: effect of photosensitization reaction parameters on myocardial necrosis in vitro." In SPIE BiOS, edited by E. Duco Jansen and Robert J. Thomas. SPIE, 2012. http://dx.doi.org/10.1117/12.907176.
Повний текст джерелаWong, Jonathan, Serdar Göktepe, and Ellen Kuhl. "Computational Simulation of Traveling Arrhythmic Waves in Myocardial Tissue." In ASME 2009 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2009. http://dx.doi.org/10.1115/sbc2009-206552.
Повний текст джерелаJulian, D. G., L. S. Borthwick, D. Reid, K. P. Jennings, R. J. Wainwright, J. C. Rodger, D. Wood, J. S. Flax, and W. S. Phillips. "APSAC versus placebo: A Multicenter Study of Safty and Early Morality in Acute Myocardial Infarction." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643619.
Повний текст джерелаMattison, Lars M., Chloe Johnson, and Paul A. Iaizzo. "Biomechanical Responses of Swine Esophagus Tissue to Irreversible Electroporation." In 2018 Design of Medical Devices Conference. American Society of Mechanical Engineers, 2018. http://dx.doi.org/10.1115/dmd2018-6963.
Повний текст джерелаShenoi, Mithun M., Xiaoqing Zhang, Ramji T. Venkatasubramanian, Erin D. Grassl, Lenny George, Stephen Schmechel, James E. Coad, and John C. Bischof. "CT Visualization and Histopathological Assessment of Cryoablation in Pulmonary Veins." In ASME 2009 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2009. http://dx.doi.org/10.1115/sbc2009-206640.
Повний текст джерелаTeixeira, Davi Vargas Freitas, Arthur da Veiga Kalil Coelho, Camila Alves Pereira, Luciana Zelante Ambiel Magalhães, Marcele Schettini, and Sônia Maria Cesar de Azevedo Silva. "Bilateral anterior cerebral infarction associated with anatomical variation in a patient with COVID-19: a case report." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.338.
Повний текст джерелаMant, M. J., P. V. Greenwood, C. T. Kappagoda, and B. C. Hamacher. "TRANSCORONARY PLATELET ACTIVATION AND CONSUMPTION IN CORONARY ARTERY DISEASE (CAD): STUDIES DURING PACING TACHYCARDIA." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643025.
Повний текст джерела